PI
COGT icon

Putnam Investments’s Cogent Biosciences COGT Stock Holding History

Putnam Investments’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$492K Buy
83,654
+55,409
+196% +$425K ﹤0.01% 936
2023
Q3 		$275K Sell
28,245
-3,149
-10% -$37.3K ﹤0.01% 1086
2023
Q2 		$372K Sell
31,394
-977
-3% -$11.2K ﹤0.01% 1013
2023
Q1 		$349K Buy
+32,371
New +$414K ﹤0.01% 1047

Other funds holding COGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments's COGT Position: Q4 2023 in Review

Putnam Investments increased its Cogent Biosciences (COGT) stake by 196% in Q4 2023, buying an estimated $425K and bringing the position to 83,654 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Putnam Investments first reported a position in COGT in Q1 2023 and has held it in 4 quarters since. 144 funds tracked by Wall St. Rank hold COGT as of Q4 2023.

  • Putnam Investments held 83,654 shares of Cogent Biosciences worth $492K as of Q4 2023.
  • Putnam Investments bought 55,409 Cogent Biosciences shares in Q4 2023, an estimated $425K.
  • Cogent Biosciences made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #936 holding.
  • Putnam Investments first reported a position in Cogent Biosciences in Q1 2023 and has held it in 4 quarters since.
  • 144 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.